What is Butformin used for?

Butformin is indicated for Diabetes mellitus type 2.

What development phase is Butformin in?

Butformin is FDA-approved (marketed).

What is the generic name of Butformin?

BUFORMIN is the generic (nonproprietary) name of Butformin.

Last reviewed 2026-04-20 · How we verify

Butformin (BUFORMIN)

FDA-approved withdrawn Small molecule Quality 15/100

At a glance

Generic name	BUFORMIN
Drug class	buformin
Modality	Small molecule
Therapeutic area	Metabolic
Phase	FDA-approved

Approved indications

Diabetes mellitus type 2

Common side effects

No common side effects on file.

Key clinical trials

Cinobufacini Tablets Combined With Chemotherapeutic Protocol in Treatment of Diffuse Large B Cell Lymphoma (PHASE2,PHASE3)
Incretin-based Drugs and Acute Pancreatitis
Incretin-based Drugs and the Risk of Heart Failure
Incretin-based Drugs and Pancreatic Cancer
A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Butformin CI brief — competitive landscape report
Butformin updates RSS · CI watch RSS